Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hexokinase 2 | 0.0161 | 0.179 | 1 |
Trypanosoma brucei | hexokinase | 0.0161 | 0.179 | 1 |
Mycobacterium tuberculosis | Possible polyprenyl synthetase IdsB (polyprenyl transferase) (polyprenyl diphosphate synthase) | 0.0107 | 0.0178 | 0.5 |
Onchocerca volvulus | 0.0161 | 0.179 | 1 | |
Brugia malayi | Polyprenyl synthetase family protein | 0.0107 | 0.0178 | 0.0178 |
Echinococcus multilocularis | hexokinase | 0.0161 | 0.179 | 0.1641 |
Brugia malayi | Polyprenyl synthetase family protein | 0.0107 | 0.0178 | 0.0178 |
Leishmania major | hexokinase, putative | 0.0161 | 0.179 | 0.1641 |
Trichomonas vaginalis | geranylgeranyl diphosphate synthase, putative | 0.0107 | 0.0178 | 0.5 |
Plasmodium falciparum | hexokinase | 0.0161 | 0.179 | 1 |
Echinococcus granulosus | hexokinase | 0.0161 | 0.179 | 0.1641 |
Wolbachia endosymbiont of Brugia malayi | geranylgeranyl pyrophosphate synthase | 0.0107 | 0.0178 | 0.5 |
Mycobacterium ulcerans | polyprenyl diphosphate synthetase, GrcC1 | 0.0107 | 0.0178 | 0.5 |
Brugia malayi | hexokinase | 0.0161 | 0.179 | 0.179 |
Chlamydia trachomatis | geranylgeranyl pyrophosphate synthase | 0.0107 | 0.0178 | 0.5 |
Trypanosoma cruzi | hexokinase, putative | 0.0161 | 0.179 | 0.1641 |
Onchocerca volvulus | 0.0161 | 0.179 | 1 | |
Echinococcus granulosus | hexokinase type 2 | 0.0161 | 0.179 | 0.1641 |
Trypanosoma cruzi | polyprenyl synthase, putative | 0.0437 | 1 | 1 |
Trypanosoma brucei | hexokinase, putative | 0.0161 | 0.179 | 1 |
Echinococcus granulosus | hexokinase | 0.0161 | 0.179 | 0.1641 |
Loa Loa (eye worm) | polyprenyl synthetase | 0.0107 | 0.0178 | 0.0178 |
Echinococcus granulosus | hexokinase | 0.0161 | 0.179 | 0.1641 |
Trichomonas vaginalis | geranylgeranyl pyrophosphate synthase, putative | 0.0107 | 0.0178 | 0.5 |
Entamoeba histolytica | hexokinase 1 | 0.0161 | 0.179 | 1 |
Loa Loa (eye worm) | hexokinase | 0.0161 | 0.179 | 0.179 |
Loa Loa (eye worm) | hexokinase type II | 0.0161 | 0.179 | 0.179 |
Mycobacterium ulcerans | polyprenyl synthetase IdsB | 0.0107 | 0.0178 | 0.5 |
Mycobacterium leprae | PROBABLE POLYPRENYL-DIPHOSPHATE SYNTHASE GRCC1 (POLYPRENYL PYROPHOSPHATE SYNTHETASE) | 0.0107 | 0.0178 | 0.5 |
Leishmania major | hexokinase, putative | 0.0161 | 0.179 | 0.1641 |
Leishmania major | polyprenyl synthase, putative | 0.0437 | 1 | 1 |
Giardia lamblia | Farnesyl diphosphate synthase | 0.0107 | 0.0178 | 0.5 |
Schistosoma mansoni | geranylgeranyl pyrophosphate synthase | 0.0437 | 1 | 1 |
Echinococcus granulosus | geranylgeranyl pyrophosphate synthase | 0.0437 | 1 | 1 |
Loa Loa (eye worm) | geranylgeranyl pyrophosphate synthetase | 0.0437 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | geranylgeranyl pyrophosphate synthase | 0.0107 | 0.0178 | 0.5 |
Trypanosoma cruzi | hexokinase, putative | 0.0161 | 0.179 | 0.1641 |
Loa Loa (eye worm) | hypothetical protein | 0.011 | 0.0263 | 0.0263 |
Trypanosoma cruzi | polyprenyl synthase, putative | 0.0437 | 1 | 1 |
Treponema pallidum | octaprenyl-diphosphate synthase | 0.0437 | 1 | 1 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.0107 | 0.0178 | 0.5 |
Onchocerca volvulus | 0.0161 | 0.179 | 1 | |
Toxoplasma gondii | hexokinase | 0.0161 | 0.179 | 1 |
Loa Loa (eye worm) | polyprenyl synthetase | 0.0107 | 0.0178 | 0.0178 |
Trichomonas vaginalis | geranylgeranyl pyrophosphate synthase, putative | 0.0107 | 0.0178 | 0.5 |
Echinococcus multilocularis | hexokinase | 0.0161 | 0.179 | 0.1641 |
Mycobacterium tuberculosis | Probable geranylgeranyl pyrophosphate synthetase IdsA2 (ggppsase) (GGPP synthetase) (geranylgeranyl diphosphate synthase) | 0.0107 | 0.0178 | 0.5 |
Echinococcus multilocularis | hexokinase type 2 | 0.0161 | 0.179 | 0.1641 |
Trypanosoma brucei | hexokinase | 0.0161 | 0.179 | 1 |
Echinococcus multilocularis | geranylgeranyl pyrophosphate synthase | 0.0437 | 1 | 1 |
Mycobacterium tuberculosis | Probable multifunctional geranylgeranyl pyrophosphate synthetase IdsA1 (GGPP synthetase) (ggppsase) (geranylgeranyl diphosphate | 0.0107 | 0.0178 | 0.5 |
Brugia malayi | Hexokinase family protein | 0.0161 | 0.179 | 0.179 |
Schistosoma mansoni | hexokinase | 0.0161 | 0.179 | 0.1641 |
Loa Loa (eye worm) | hexokinase | 0.0161 | 0.179 | 0.179 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.0107 | 0.0178 | 0.5 |
Mycobacterium tuberculosis | Probable polyprenyl-diphosphate synthase GrcC2 (polyprenyl pyrophosphate synthetase) | 0.0107 | 0.0178 | 0.5 |
Echinococcus multilocularis | hexokinase | 0.0161 | 0.179 | 0.1641 |
Plasmodium vivax | hexokinase, putative | 0.0161 | 0.179 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0.036 uM | The compound was evaluated for the growth inhibition of Dx5 w/PSC cell lines using MTT assay. | ChEMBL. | 10698449 |
IC50 (functional) | = 0.036 uM | The compound was evaluated for the growth inhibition of Dx5 w/PSC cell lines using MTT assay. | ChEMBL. | 10698449 |
IC50 (functional) | = 0.099 uM | The compound was evaluated for the growth inhibition of MES-SA uterine tumor cell lines using MTT assay. | ChEMBL. | 10698449 |
IC50 (functional) | = 0.099 uM | The compound was evaluated for the growth inhibition of MES-SA uterine tumor cell lines using MTT assay. | ChEMBL. | 10698449 |
IC50 (functional) | = 16 uM | The compound was evaluated for the growth inhibition of Dx5 cell lines using MTT assay. | ChEMBL. | 10698449 |
IC50 (functional) | = 16 uM | The compound was evaluated for the growth inhibition of Dx5 cell lines using MTT assay. | ChEMBL. | 10698449 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 10698449 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.